Literature DB >> 9578859

Effect on attendance at breast cancer screening of adding a self administered questionnaire to the usual invitation to breast screening in southern England.

E Banks1, A Richardson, V Beral, B Crossley, M Simmonds, E Hilton, R English, J Davis, J Austoker.   

Abstract

STUDY
OBJECTIVE: The primary aim of the research described in this paper was to ascertain whether inclusion of a self administered questionnaire with the usual invitation to routine breast screening affected screening uptake. Secondary aims included establishing appropriate questionnaire distribution and collection methods within the framework of the National Health Service Breast Screening Programme and optimisation of questionnaire design.
DESIGN: Randomised study.
SETTING: Oxfordshire and West of London Breast Screening Units. PARTICIPANTS/
METHODS: 6400 women invited for routine screening mammography were individually randomised to receive either the usual breast screening invitation alone, or to receive the usual invitation accompanied by a self administered questionnaire, to be returned at the time of screening. Participants were then followed up and attendance rates at screening were compared between groups. MAIN
RESULTS: Screening attendance rates were similar in women who did and did not receive a questionnaire (71% in each group). Of those who were sent a questionnaire and attended for screening, 77% returned a completed questionnaire. Screening uptake was not affected by the way in which the questionnaire was returned or by whether or not personal details and signed permission for follow up were requested.
CONCLUSIONS: The inclusion of a self administered questionnaire accompanying the invitation to breast screening did not adversely affect screening uptake. A high proportion of women completed the questionnaire.

Entities:  

Mesh:

Year:  1998        PMID: 9578859      PMCID: PMC1756668          DOI: 10.1136/jech.52.2.116

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  4 in total

1.  Monovision correction for diplopia.

Authors:  R London
Journal:  J Am Optom Assoc       Date:  1987-07

2.  Effect on breast cancer screening response in The Netherlands of inviting women for an additional scientific investigation.

Authors:  P H Peeters; C G Beckers; J M Hogervorst; H J Collette
Journal:  J Epidemiol Community Health       Date:  1994-04       Impact factor: 3.710

3.  Women doctors' use of hormone replacement therapy. High prevalence of use is not confined to doctors.

Authors:  E Banks; B Crossley; R English; A Richardson
Journal:  BMJ       Date:  1996-03-09

4.  Utilisation of hormone replacement therapy by women doctors.

Authors:  A J Isaacs; A R Britton; K McPherson
Journal:  BMJ       Date:  1995-11-25
  4 in total
  4 in total

1.  The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group.

Authors: 
Journal:  Breast Cancer Res       Date:  1999-08-19       Impact factor: 6.466

2.  Cyprus Women's Health Research (COHERE) initiative: determining the relative burden of women's health conditions and related co-morbidities in an Eastern Mediterranean population.

Authors:  M B Hocaoglu; S Gurkas; T Karaderi; B Taneri; K Erguler; B Barin; E M Bilgin; G Eralp; M Allison; N Findikli; K Boynukalin; M Bahceci; H Naci; K Vincent; S A Missmer; C M Becker; K T Zondervan; N Rahmioglu
Journal:  BMC Womens Health       Date:  2019-04-03       Impact factor: 2.809

3.  Rapid review of evaluation of interventions to improve participation in cancer screening services.

Authors:  Stephen W Duffy; Jonathan P Myles; Roberta Maroni; Abeera Mohammad
Journal:  J Med Screen       Date:  2016-10-17       Impact factor: 2.136

4.  Cohort Profile: the Million Women Study.

Authors:  Jane Green; Gillian K Reeves; Sarah Floud; Isobel Barnes; Benjamin J Cairns; Toral Gathani; Kirstin Pirie; Siân Sweetland; TienYu Owen Yang; Valerie Beral
Journal:  Int J Epidemiol       Date:  2019-02-01       Impact factor: 7.196

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.